FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912954741> ?p ?o ?g. }

• W2912954741 endingPage "459" @default.
• W2912954741 startingPage "443" @default.
• W2912954741 abstract "Frontotemporal dementia refers to a group of progressive neurodegenerative syndromes usually caused by the accumulation of pathological tau or TDP-43 proteins. The effects of these proteins in the brain are complex, and each can present with several different clinical syndromes. Clinical efficacy trials of drugs targeting these proteins must use endpoints that are meaningful to all participants despite the variability in symptoms across patients. There are many candidate clinical measures, including neuropsychological scores and functional measures. Brain imaging is another potentially attractive outcome that can be precisely quantified and provides evidence of disease modification. Most imaging studies in frontotemporal dementia have been cross-sectional, and few have compared longitudinal changes in cortical volume with changes in other measures such as perfusion and white matter integrity. The current study characterized longitudinal changes in 161 patients with three frontotemporal dementia syndromes: behavioural variant frontotemporal dementia (n = 77) and the semantic (n = 45) and non-fluent (n = 39) variants of primary progressive aphasia. Visits included comprehensive neuropsychological and functional assessment, structural MRI (3 T), diffusion tensor imaging, and arterial spin labelled perfusion imaging. The goal was to identify measures that are appropriate as clinical trial outcomes for each group, as well as those that might be appropriate for trials that would include more than one of these groups. Linear mixed effects models were used to estimate changes in each measure, and to examine the correlation between imaging and clinical changes. Sample sizes were estimated based on the observed effects for theoretical clinical trials using bootstrapping techniques to provide 95% confidence intervals for these estimates. Declines in functional and neuropsychological measures, as well as frontal and temporal cortical volumes and white matter microstructure were detected in all groups. Imaging changes were statistically significantly correlated with, and explained a substantial portion of variance in, the change in most clinical measures. Perfusion and diffusion tensor imaging accounted for variation in clinical decline beyond volume alone. Sample size estimates for atrophy and diffusion imaging were comparable to clinical measures. Corpus callosal fractional anisotropy led to the lowest sample size estimates for all three syndromes. These findings provide further guidance on selection of trial endpoints for studies in frontotemporal dementia and support the use of neuroimaging, particularly structural and diffusion weighted imaging, as biomarkers. Diffusion and perfusion imaging appear to offer additional utility for explaining clinical change beyond the variance explained by volume alone, arguing for considering multimodal imaging in treatment trials." @default.
• W2912954741 created "2019-02-21" @default.
• W2912954741 creator A5003878251 @default.
• W2912954741 creator A5004960360 @default.
• W2912954741 creator A5009189242 @default.
• W2912954741 creator A5013941877 @default.
• W2912954741 creator A5019555711 @default.
• W2912954741 creator A5024419194 @default.
• W2912954741 creator A5025008902 @default.
• W2912954741 creator A5026607111 @default.
• W2912954741 creator A5027791567 @default.
• W2912954741 creator A5037972521 @default.
• W2912954741 creator A5040497314 @default.
• W2912954741 creator A5043432683 @default.
• W2912954741 creator A5059027860 @default.
• W2912954741 creator A5062212095 @default.
• W2912954741 creator A5066352714 @default.
• W2912954741 creator A5067197765 @default.
• W2912954741 creator A5072009949 @default.
• W2912954741 creator A5074694043 @default.
• W2912954741 creator A5084740171 @default.
• W2912954741 creator A5086955468 @default.
• W2912954741 creator A5089758689 @default.
• W2912954741 date "2019-01-29" @default.
• W2912954741 modified "2023-10-16" @default.
• W2912954741 title "Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials" @default.
• W2912954741 cites W1202665417 @default.
• W2912954741 cites W1556842271 @default.
• W2912954741 cites W1569179567 @default.
• W2912954741 cites W1586285828 @default.
• W2912954741 cites W1680322590 @default.
• W2912954741 cites W1742833546 @default.
• W2912954741 cites W1847168837 @default.
• W2912954741 cites W1970283678 @default.
• W2912954741 cites W1971351343 @default.
• W2912954741 cites W1974583546 @default.
• W2912954741 cites W1978116973 @default.
• W2912954741 cites W1984148891 @default.
• W2912954741 cites W1991952617 @default.
• W2912954741 cites W2008854521 @default.
• W2912954741 cites W2024034758 @default.
• W2912954741 cites W2027467488 @default.
• W2912954741 cites W2028590696 @default.
• W2912954741 cites W2043778544 @default.
• W2912954741 cites W2058161128 @default.
• W2912954741 cites W2061821269 @default.
• W2912954741 cites W2080763041 @default.
• W2912954741 cites W2085870059 @default.
• W2912954741 cites W2102613865 @default.
• W2912954741 cites W2106046611 @default.
• W2912954741 cites W2106786486 @default.
• W2912954741 cites W2108583813 @default.
• W2912954741 cites W2111963393 @default.
• W2912954741 cites W2112519660 @default.
• W2912954741 cites W2120357670 @default.
• W2912954741 cites W2123136773 @default.
• W2912954741 cites W2128030851 @default.
• W2912954741 cites W2129006179 @default.
• W2912954741 cites W2138190873 @default.
• W2912954741 cites W2148080316 @default.
• W2912954741 cites W2152018727 @default.
• W2912954741 cites W2154633730 @default.
• W2912954741 cites W2159781745 @default.
• W2912954741 cites W2161309912 @default.
• W2912954741 cites W2161420216 @default.
• W2912954741 cites W2161762785 @default.
• W2912954741 cites W2167311298 @default.
• W2912954741 cites W2173327703 @default.
• W2912954741 cites W2179914359 @default.
• W2912954741 cites W2281205902 @default.
• W2912954741 cites W2385703614 @default.
• W2912954741 cites W2418725963 @default.
• W2912954741 cites W2443339653 @default.
• W2912954741 cites W2494252203 @default.
• W2912954741 cites W2506919437 @default.
• W2912954741 cites W2517051545 @default.
• W2912954741 cites W2534085153 @default.
• W2912954741 cites W2560149596 @default.
• W2912954741 cites W2586159641 @default.
• W2912954741 cites W2596951075 @default.
• W2912954741 cites W2601677619 @default.
• W2912954741 cites W2619097621 @default.
• W2912954741 cites W2625796101 @default.
• W2912954741 cites W2785610956 @default.
• W2912954741 cites W4211205454 @default.
• W2912954741 cites W4241885035 @default.
• W2912954741 cites W4241931797 @default.
• W2912954741 doi "https://doi.org/10.1093/brain/awy319" @default.
• W2912954741 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6351779" @default.
• W2912954741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30698757" @default.
• W2912954741 hasPublicationYear "2019" @default.
• W2912954741 type Work @default.
• W2912954741 sameAs 2912954741 @default.
• W2912954741 citedByCount "62" @default.
• W2912954741 countsByYear W29129547412019 @default.
• W2912954741 countsByYear W29129547412020 @default.
• W2912954741 countsByYear W29129547412021 @default.
• W2912954741 countsByYear W29129547412022 @default.

• next